Skip to main content
logo
Goldenwell Biotech, Inc. (GWLL)
OTCMKTS · Delayed Price · Currency is USD
0.7000
0.00 (0.00%)
At close: Aug 20, 2026

Goldenwell Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6928720629-
Market Cap Growth
250.00%1350.00%241.30%-80.14%--
Enterprise Value
7028720629-
Last Close Price
0.702.900.200.060.29-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1260000.005220000.00142446.043159.80610.98-
PB Ratio
-174.04-835.29-419.1368.85144.85-
P/TBV Ratio
---68.85144.85-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-5224186.36143832.523196.89610.38-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.82-0.81-5.711.680.230.16
Net Debt / Equity Ratio
-0.79-0.73-4.661.050.00-0.55
Asset Turnover
000.000.010.140.05
Inventory Turnover
-2.0000.010.12-
Quick Ratio
0.110.2626.5627.811.721.34
Current Ratio
0.290.36120.53119.178.292.59
Return on Equity (ROE)
---710.49%-82.11%-391.43%-42.52%
Return on Assets (ROA)
-129.14%-138.33%-34.02%-30.39%-173.59%-20.84%
Return on Capital Employed (ROCE)
407.70%438.20%-55.40%-51.20%-444.50%-39.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.41%-0.10%-0.66%-2.02%-3.37%-
Buyback Yield / Dilution
1.28%---2.66%-5.60%-12.80%